Détail de la notice
Titre du Document
A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome
Auteur(s)
PETERSON P. K. ; PHELEY A. ; SCHROEPPEL J. ; ...
Résumé
Objective: To provide a preliminary assessment of the efficacy and safety of fludrocortisone acetate treatment of chronic fatigue syndrome. Design: A placebo-controlled, double-blind, random-allocation crossover trial of 6 weeks of fludrocortisone. Setting: An outpatient clinical trials unit. Patients: Twenty-five participants with chronic fatigue syndrome (mean age, 40 years; 19 [76%] women; mean duration of illness, 7.0 years) were recruited from a research and clinic registry. Five patients withdrew from the trial. Interventions: All participants were scheduled to receive fludrocortisone acetate (0.1-0.2 mg) or a placebo for 6 weeks in each treatment. Main Outcome Measures: Self-administered questionnaires were completed at the beginning and end of each treatment arm that asked patients to rate the severity of their symptoms on a visual analogue scale. The Medical Outcomes Study 36-Item Short-Form Health Survey, a reaction time test, and a treadmill exercise test were used to assess functional status. Blood pressure, heart rate, and plasma norepinephrine levels were obtained at baseline. Blood pressure and heart rate were recorded at the end of the exercise test and monitored at all subsequent visits. Results: At baseline, the study participants reported symptom severity greater than 5 for most symptoms, and all had evidence of marked functional impairments. No improvement was observed in the severity of any symptom or in any test of function for the 20 participants who co
Editeur
American Medical Association
Identifiant
PMID : 9570178 ISSN : 0003-9926 CODEN : AIMDAP
Source
Archives of internal medicine (1960) A. 1998, vol. 158, n° 8, pp. 908-914 [bibl. : 28 ref.]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :